Image credit: Jeremy Buckingham

Federal Lobbying on Cannabis Dipped in the First Part of 2020

Compared to the last quarter, spending on cannabis-related issues is down somewhat, though some entities are pushing for coronavirus relief.

Lobbying
New York

New York: Cannabis and the Cuomo Effect

While Cuomo’s scandals might have helped push legalization over the finish line in 2021, the latest fallout could cause delays in setting up the industry.

CBD

Cannabis and Clinical Trials: How the First Cannabis Extract Got FDA Approval

CSU Pueblo hosted a pharmacist at Greenwich Biosciences to talk about the company’s path with Epidiolex, a CBD-based medicine extracted from cannabis plants.